Resistance Oncology ApS
-
-
Active
- Registration 36945125
Relations
Past relations
- Subsidiaries
-
-
Linker Pharmaceuticals ApS 100% ownership (2023-09-22 – 2025-06-18 ) 90% ownership (2025-06-19 – ) 100% voting rights (2023-09-22 – 2025-06-18 ) 90% voting rights (2025-06-19 – )
-
Linker Pharmaceuticals ApS 100% ownership (2023-09-22 – 2025-06-18 ) 90% ownership (2025-06-19 – ) 100% voting rights (2023-09-22 – 2025-06-18 ) 90% voting rights (2025-06-19 – )
-
Financial reports
Revenue
Profit/loss
| '000 | 12-2016 | 12-2017 | |
|---|---|---|---|
| Currency | DKK | DKK | |
| Revenue | 0 | 0 | |
| Raw materials and consumables used | 0 | 0 | |
| Other external expenses | 0 | 0 | |
| Gross profit loss | -1,666 | 51 | |
| Employee benefits expense | 1,772 | 0 | |
| Wages and salaries | 0 | 0 | |
| Depreciation amortisation expense and impairment losses of prop | 0 | 0 | |
| Profit loss from ordinary operating activities | -3,438 | 51 | |
| Profit loss from ordinary activities before tax | -3,614 | 1,149 | |
| Other finance expenses | 178 | 46 | |
| Tax expense | -793 | 1 | |
| Profit loss | -2,821 | 1,147 |